CIC
CELG

Carnegie Investment Counsel’s Celgene Corp CELG Stock Holding History

Carnegie Investment Counsel’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,290
Closed -$227K – 443
2019
Q3 		$227K Buy
2,290
+120
+6% +$11.4K 0.01% 394
2019
Q2 		$201K Sell
2,170
-1,900
-47% -$180K 0.01% 414
2019
Q1 		$384K Sell
4,070
-4,104
-50% -$359K 0.03% 330
2018
Q4 		$524K Buy
8,174
+2,170
+36% +$160K 0.05% 252
2018
Q3 		$417K Sell
6,004
-4,528
-43% -$400K 0.03% 258
2018
Q2 		$976K Sell
10,532
-17
-0.2% -$1.41K 0.07% 206
2018
Q1 		$892K Sell
10,549
-728
-6% -$69.9K 0.07% 198
2017
Q4 		$1.07M Sell
11,277
-293
-3% -$33.1K 0.1% 207
2017
Q3 		$1.41M Buy
11,570
+254
+2% +$34.6K 0.17% 156
2017
Q2 		$1.53M Hold
11,316
– – 0.19% 138
2017
Q1 		$1.35M Buy
11,316
+1,450
+15% +$174K 0.17% 142
2016
Q4 		$1.17M Sell
9,866
-222
-2% -$24.7K 0.16% 146
2016
Q3 		$1M Buy
10,088
+200
+2% +$21.6K 0.15% 150
2016
Q2 		$1.06M Buy
9,888
+575
+6% +$59.5K 0.15% 154
2016
Q1 		$932K Buy
9,313
+375
+4% +$38.6K 0.14% 164
2015
Q4 		$890K Buy
8,938
+2,260
+34% +$261K 0.15% 154
2015
Q3 		$840K Buy
6,678
+4,795
+255% +$595K 0.14% 155
2015
Q2 		$218K Sell
1,883
-542
-22% -$62K 0.04% 269
2015
Q1 		$281K Buy
2,425
+192
+9% +$22.9K 0.05% 249
2014
Q4 		$257K Sell
2,233
-199
-8% -$21K 0.05% 244
2014
Q3 		$231K Buy
+2,432
New +$219K 0.05% 265

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Carnegie Investment Counsel's CELG Position: Q4 2019 in Review

Carnegie Investment Counsel sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,290 shares — an estimated $227K sold.

Carnegie Investment Counsel first reported a position in CELG in Q3 2014 and held it in 21 quarters. The position peaked at $1.53M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Carnegie Investment Counsel reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Carnegie Investment Counsel sold 2,290 Celgene Corp shares in Q4 2019, an estimated $227K.
  • Carnegie Investment Counsel first reported a position in Celgene Corp in Q3 2014 and held it in 21 quarters.
  • Carnegie Investment Counsel's Celgene Corp position peaked at $1.53M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Carnegie Investment Counsel's 13F filing for Q4 2019, filed 13 Feb 2020.